Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

SteadyMed Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Tel Aviv, Israel Founded 2005 11-50 employees For Profit

SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

SteadyMed Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

SteadyMed Therapeutics was acquired by United Therapeutics in 2018.
Total Funding
$84.2M
Funding Rounds
7
Last Funding
Acquisitions
0
Monthly Visits
Contacts
1
Ticker
STDY
NASDAQ
Patents
10
3 trademarks

About SteadyMed Therapeutics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
STDY
Exchange
NASDAQ
IPO date
Mar 20, 2015
Raised at IPO
$40M
Valuation at IPO
$160M

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
5
Active products
17
Patents granted
10
Trademarks
3
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2005
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
2
News articles
9
HQ
Tel Aviv, Israel
Region
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
Exit date
Mar 20, 2015
Closed
Aug 30, 2018

Signals & Scores

Heat score
Low
Trend (7d)
0
Trend (30d)
-0.3
Trend (90d)
-0.3

SteadyMed Therapeutics Funding Rounds

7 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–5 of 7Show
Page 1 / 2

SteadyMed Therapeutics Key People

Co-Founder & VP Business Development.
VP of Operations
SVP of Regulatory Affairs
VP of Drug Product Development
Board of Directors
Director of Marketing & U.S. Business Development
1
professional contacts at SteadyMed Therapeutics
Contact execs at SteadyMed Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to SteadyMed Therapeutics

Loading news…

FAQs about SteadyMed Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.